DarioHealth (NASDAQ:DRIO) Share Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

DarioHealth Corp. (NASDAQ:DRIO)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.79 and traded as low as $0.54. DarioHealth shares last traded at $0.56, with a volume of 178,400 shares.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on DRIO shares. Stifel Nicolaus lowered their price objective on shares of DarioHealth from $3.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, March 11th. TD Cowen lowered DarioHealth from a “buy” rating to a “hold” rating and dropped their price target for the company from $2.00 to $1.00 in a research report on Wednesday, January 29th.

DarioHealth Stock Down 2.8 %

The company has a quick ratio of 1.32, a current ratio of 1.57 and a debt-to-equity ratio of 0.35. The company’s fifty day moving average price is $0.66 and its 200-day moving average price is $0.79. The stock has a market capitalization of $23.28 million, a PE ratio of -0.60 and a beta of 1.42.

Institutional Investors Weigh In On DarioHealth

An institutional investor recently raised its position in DarioHealth stock. XTX Topco Ltd lifted its holdings in shares of DarioHealth Corp. (NASDAQ:DRIO) by 81.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,455 shares of the company’s stock after buying an additional 13,219 shares during the period. XTX Topco Ltd owned approximately 0.09% of DarioHealth worth $33,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 33.39% of the company’s stock.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.